神経修復・再生市場：製品・手術・地域別、2024～2031年

神経修復・再生市場の評価 - 2024～2031年

神経損傷、神経疾患、糖尿病などの慢性疾患の有病率の上昇により、効果的な神経再生治療の必要性が高まっています。再生医療の研究開発に資金を提供するための政府の施策や、侵襲性の低い手技の使用の増加が、市場拡大に寄与しています。さらに、オーダーメイド医療やより特異的な医薬品の開発が重視されるようになったことで、この分野に新たな展望が生まれており、2024年には88億4,000万米ドル、2031年には158億8,000万米ドルに達すると予測されています。

生体材料、幹細胞治療、3Dプリンティングなどの医療技術の進歩は、神経修復治療の成功を向上させています。さらに、高齢化とともに早期介入の利点に対する認識が高まっていることも、市場成長の原動力となっており、2024年から2031年までのCAGRは約8.37%です。

神経修復・再生市場定義/概要

神経修復・再生とは、損傷したり傷ついたりした神経組織を修復して再び機能するようにするプロセスです。神経移植片、生体材料ベースの足場、幹細胞治療、神経刺激などを用いて治癒と再生を促進します。末梢神経損傷、脊髄損傷、神経変性疾患、糖尿病性神経障害などの治療に応用されています。遺伝子編集、バイオエレクトロニクス医療、個別化された再生技術など、先進的な治療法の継続的な調査により、神経の修復と再生の未来は希望に満ちています。継続的な技術の進歩と神経細胞生物学に対するより深い理解がブレークスルーを促し、より効果的で迅速な治療オプションが期待されます。

個別化医療への注目の高まりは神経修復・再生市場を促進するか？

個別化医療が重視されるようになったことで、神経修復・再生産業は大きく成長すると予想されます。個別化医療は、個人の遺伝的プロファイル、疾患の特徴、その他のバイオマーカーに合わせて治療法を調整するもので、神経疾患のような複雑な疾患には特に有効です。遺伝子治療、幹細胞治療、生体材料の改良など、神経修復のための個別化技術は、より効果的でオーダーメイドの治療を可能にしています。

2023年10月、米国立衛生研究所（NIH）は、個別化された神経再生技術の創造的研究を刺激するため、今後5年間で2億米ドルの資金増額を発表しました。さらに、FDAは神経疾患に対する個別化医薬品の認可を続けており、これによって新薬がより迅速に市場に投入されるようになっています。Statistaによると、個別化医療の世界市場は2023年に5,000億米ドルと評価され、2024年から2030年にかけて11.5％のCAGRで増加すると予想されています。その結果、オーダーメイド医療が重視されるようになったことで、治療法が改善されるだけでなく、神経修復・再生産業全体の拡大が促進され、患者により正確で効率的かつ効果的なソリューションが提供されるようになっています。

神経組織再生の複雑化は神経修復・再生市場の成長を妨げるか？

神経組織再生の複雑化は、神経修復・再生分野の拡大に大きな障害となっています。特に中枢神経系の神経組織は、成熟した神経細胞の再生能力が限られているため、当然ながら治癒が難しいです。瘢痕組織の形成、免疫系の反応、神経ネットワークの複雑さなど、すべてが治療の成功を困難にしています。さらに、生体材料、幹細胞治療、遺伝子編集の進歩は大きな可能性を示していますが、これらの技術を複雑な損傷に対する実用的で安全な成功する治療に結びつけることは、依然として大きな課題です。このような複雑さが、開発期間の長期化、研究コストの増大、規制上の障壁となり、産業全体の成長を低下させています。

しかし、神経組織再生の複雑さが障害となる一方で、それが業界のイノベーションを刺激することも事実です。研究が進むにつれ、これらの障害に対処するため、3Dプリント足場、遺伝子治療、オーダーメイド治療などの新しいアプローチが研究されています。さらに、神経疾患の有病率の上昇は、再生医療への資金提供の増加と相まって、将来のブレークスルーへの大きなインセンティブを生み出しています。このような困難は当面の市場成長を鈍らせるかもしれませんが、ユニークな解決策の可能性も提供し、長期的には、より効果的な新しい治療法が利用可能になるにつれて、市場の進化を加速させるかもしれません。

目次

第1章 世界の神経修復・再生市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 神経修復・再生の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 神経修復・再生の世界市場：製品別

• 概要
• 神経刺激および神経調節デバイス
• バイオマテリアル

第6章 神経修復・再生の世界市場：手術別

• 概要
• 神経移植術
• 幹細胞治療

第7章 神経修復・再生の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の神経修復・再生市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Medtronic's Plc
• Axogen Corporation
• Baxter International Inc.
• Polygamic
• Integra LiveScience
• Cyberonics Inc.
• Stryker Corporation
• St. Judge Medical Inc.
• Boston Scientific Corporation
• Emerson Electric Company

第10章 主な発展

• 製品上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第11章 付録

• 関連調査

Nerve Repair and Regeneration Market Valuation - 2024-2031

The rising prevalence of nerve injuries, neurological illnesses, and chronic diseases like diabetes is increasing the need for effective nerve regeneration treatments. Government measures to fund regenerative medicine research and development, as well as increased use of less invasive procedures, are all contributing to market expansion. Furthermore, the increased emphasis on customized medicine and the development of more specific medicines are creating new prospects in the field is fueling the USD 8.84 Billion in 2024 and reaching USD 15.88 Billion by 2031.

Advances in medical technology, such as biomaterials, stem cell therapies, and 3D printing, are improving the success of nerve repair treatments. Furthermore, increasing awareness of the benefits of early intervention, along with an aging population, is driving market growth is grow at a CAGR of about 8.37% from 2024 to 2031.

Nerve Repair and Regeneration Market: Definition/ Overview

Nerve repair and regeneration is the process of repairing damaged or injured nerve tissues so that they can function again. It uses nerve grafts, biomaterial-based scaffolds, stem cell therapy, and neurostimulation to promote healing and regeneration. Applications include the therapy of peripheral nerve injuries, spinal cord injuries, neurodegenerative disorders, and diabetic neuropathy. The future of nerve repair and regeneration looks hopeful, with continuous research into advanced therapeutics including gene editing, bioelectronic medicine, and individualized regenerative techniques. Continued technology advancements and a better understanding of neuron biology are expected to drive breakthroughs, providing promise for more effective and faster healing options.

Will Rising Focused on Personalized Medicine Propel the Nerve Repair And Regeneration Market?

The increasing emphasis on personalized therapy is expected to greatly boost the nerve repair and regeneration industry. Personalized medicine tailors therapies to individuals' genetic profiles, disease characteristics, and other biomarkers, which is especially useful for complicated ailments such as neurological disorders. Personalized techniques to nerve repair, such as gene therapies, stem cell treatments, and biomaterial modification, are enabling more effective and tailored therapies.

In October 2023, the National Institutes of Health (NIH) announced a USD 200 Million funding increase over the following five years to stimulate creative research into individualized nerve regeneration techniques. Furthermore, the FDA continues to approve tailored medicines for neurological diseases, which allows novel medications to enter the market more quickly. According to Statista, the global market for personalized medicine was valued at USD 500 Billion in 2023 and is expected to increase at an 11.5% CAGR between 2024 and 2030. As a result, the growing emphasis on customized medicine is not only improving therapeutic alternatives, but also driving the overall expansion of the nerve repair and regeneration industry, providing more accurate, efficient, and effective solutions to patients.

Will Rising Complexity of Nerve Tissue Regeneration Hinder the Growth of the Nerve Repair and Regeneration Market?

The increasing complexity of nerve tissue regeneration poses a significant obstacle to the expansion of the nerve repair and regeneration sector. Nerve tissue, particularly in the central nervous system, is naturally difficult to heal because mature neurons have limited regenerative ability. Scar tissue formation, immune system responses, and the complexity of neural networks all make successful treatment difficult. Furthermore, while advances in biomaterials, stem cell therapy, and gene editing show great promise, turning these technologies into practical, safe, and successful treatments for complicated injuries remains a significant challenge. This complexity results in longer development timeframes, greater research costs, and regulatory barriers, reducing total industry growth.

However, while the complexity of nerve tissue regeneration creates obstacles, it also stimulates industry innovation. As research progresses, novel approaches such as 3D-printed scaffolds, gene therapies, and tailored treatments are being investigated to address these obstacles. Furthermore, the rising prevalence of neurological illnesses, combined with greater funding in regenerative medicine, creates a significant incentive for future breakthroughs. While the difficulties may slow immediate market growth, they also provide potential for unique solutions, which, in the long run, may accelerate the market's evolution as new, more effective treatments become available.

Category-Wise Acumens

Will Rising Demand of Biomaterials Propel the Nerve Repair And Regeneration Market?

The biomaterials segment is expected to hold major share in the nerve repair and regeneration market, since these materials are essential for facilitating the mending of damaged nerves. Biomaterials, such as nerve conduits, scaffolds, and grafts, can help bridge nerve gaps and promote tissue regeneration, particularly in situations of peripheral nerve injury. Biomaterials have received widespread popularity as a result of advances in material science, such as the development of biocompatible, biodegradable, and synthetic choices, and their proven efficiency in nerve repair. Leading firms such as AxoGen, Inc. and Integra LifeSciences are developing biomaterial-based solutions, with AxoGen's Avance Nerve Graft being a notable example. According to a Verified Market Research the biomaterials market is predicted to exhibit a CAGR of 14.80%, driven by growing clinical uses and technological advances in nerve regeneration products.

In April 2023, The US Food and Drug Administration (FDA) approved novel biomaterial-based nerve healing devices, speeding up the clearance process and encouraging additional companies to innovate in this area. Furthermore, the European Union's Horizon 2020 initiative has provided significant financing for research into regenerative medicine and advanced biomaterials, accelerating market growth. With an increasing prevalence of nerve injuries and neurological illnesses, as well as greater investment in research and product development, demand for biomaterials is predicted to rise further, stimulating additional growth in the nerve repair and regeneration market.

However, the neurostimulation and neuromodulation devices market is the fastest expanding, driven by rising demand for non-invasive therapies for neurological illnesses and chronic pain. Technologies such as transcranial magnetic stimulation (TMS) and spinal cord stimulation (SCS) are gaining appeal as alternatives to standard surgical therapies, propelling the category forward. Neurostimulation devices are expected to rise rapidly in the next years as a result of ongoing technology innovations and increased patient awareness.

Will Rising Innovation of Nerve Grafting Fuel the Nerve Repair And Regeneration Market?

The increasing innovation in nerve grafting is expected to greatly boost the growth of the nerve repair and regeneration market, as well as upsurge its dominance over the forecast period. Nerve grafting, which uses autografts, allografts, or synthetic materials to bridge nerve gaps, has long been a staple of peripheral nerve healing. However, recent advances in nerve grafting procedures, such as the invention of bioengineered and biodegradable grafts, have resulted in better results for patients with complex nerve injuries.

In June 2023, the National Institutes of Health (NIH) announced a USD 30 Million grant to research initiatives aimed at increasing neuron regeneration through new grafting techniques such as tissue-engineered scaffolds. In March 2023, the European Commission's Horizon Europe initiative, which began, has committed funds to assist advanced biomaterial research for nerve rehabilitation, including the creation of next-generation grafts. These advancements, combined with a growing knowledge of nerve grafting's importance in treating nerve injuries, are projected to drive market growth. As new technology and techniques improve, nerve grafting will undoubtedly become more popular, making it a crucial driver of growth in the nerve repair and regeneration industry.

However, stem cell therapy is the fastest-growing component of this science. Stem cell-based treatments have the potential to significantly improve nerve regeneration by boosting tissue repair, increasing growth hormones, and minimizing scar formation. With developments in regenerative medicine and ongoing clinical trials, stem cell therapy is gaining popularity as a novel alternative to standard treatments. The expanding emphasis on regeneration techniques, combined with promising results from recent studies, is driving the rapid growth of this market, with an increasing number of hospitals and research institutions implementing stem cell therapies in nerve repair.

Country/Region-wise

Will Rising Advanced Healthcare Infrastructure in North America Drive the Nerve Repair And Regeneration Market?

The growing advanced healthcare infrastructure in North America is projected to play a significant role in driving the region's leadership in the nerve repair and regeneration market. The region has cutting-edge healthcare facilities, dynamic research and development ecosystems, and a high level of investment in medical technologies, all of which contribute to the quick acceptance of advanced nerve regeneration therapies. Companies such as Medtronic, AxoGen, and Integra LifeSciences are exploiting North America's infrastructure to launch novel nerve repair devices and therapies. Furthermore, the rising prevalence of neurological diseases, combined with a strong demand for less invasive therapies, has propelled the market's growth.

In September 2023, The United States government would contribute $50 million to advance nerve healing technology research through the National Institutes of Health (NIH). Furthermore, the FDA has accelerated the approval of numerous nerve repair treatments, including AxoGen's Avance Nerve Graft, which has become widely used in clinical settings. These efforts not only speed up the availability of novel treatments, but they also ensure that healthcare providers have access to cutting-edge technology. With rising patient demand and a favorable legislative and financial climate, North America's modern healthcare infrastructure is expected to propel significant growth in the nerve repair and regeneration market, paving the way for future innovation and accessibility.

Will Growing Awareness of Nerve Regeneration Treatments in Asia Pacific Propel the Nerve Repair and Regeneration Market?

The increasing awareness of nerve regeneration treatments in the Asia-Pacific region is projected to drive the nerve repair and regeneration market. With a rapidly developing healthcare industry, improved access to advanced medical treatments, and a growing emphasis on neurological health, there is a greater need for novel nerve repair options. As the frequency of nerve injuries, neurological illnesses such as Parkinson's disease, and diabetes-related neuropathy rises in China, India, and Japan, healthcare practitioners and patients are becoming more aware of the benefits of nerve regeneration therapy.

In September 2023, the Indian Ministry of Health and Family Welfare announced the launch of new healthcare programs aiming at boosting access to cutting-edge treatments such as nerve repair technologies. Similarly, China has made considerable investments in regenerative medicine research through its 14th Five-Year Plan (2021-2025), which includes funding for sophisticated healthcare technology such as stem cell therapies and bioengineering solutions. These government efforts, together with the growing use of minimally invasive surgical procedures and more patient awareness, are helping to drive market growth.

Competitive Landscape

The nerve repair and regeneration market is characterized by a competitive landscape driven by advancements in biomaterials, stem cell therapies, and nerve conduit technologies. Companies are increasingly focusing on developing novel solutions for peripheral nerve injuries, spinal cord regeneration, and neurological disorders. Key strategies include strategic partnerships, acquisitions, and the development of products with enhanced efficacy and minimal side effects. Additionally, emerging technologies like 3D printing, gene therapy, and neurostimulation are opening new avenues for treatment. The market is also shaped by increasing healthcare awareness, aging populations, and growing demand for minimally invasive procedures.

Some of the prominent players operating in the nerve repair and regeneration market include:

Medtronics plc

Axogen Corporation

Baxter International, Inc.

Polyganics

Integra LifeSciences

Cyberonics, Inc.

Stryker Corporation

Jude Medical, Inc.

Boston Scientific Corporation.

Latest Developments

In May 2023, Stryker Corporation acquired Wright Medical Group to extend its range of regenerative medicine and nerve repair products. The acquisition expands Stryker's expertise in tissue healing and bioengineering, establishing the business as a stronger participant in the nerve regeneration market, particularly in severe nerve injuries.

In August 2023, Integra LifeSciences revealed their innovative NeuraGen(R) 3D Nerve Conduit, which is intended to create an ideal environment for nerve regeneration. This breakthrough employs a revolutionary 3D matrix technology that promotes cell development and long-term healing, particularly in bigger nerve gaps. Integra's growth is projected to solidify its position in the peripheral nerve repair industry.

Nerve Repair and Regeneration Market, By Category

• Product:
• Neurostimulation and Neuromodulation Devices
• Biomaterial
• Surgery:
• Nerve Grafting
• Stem Cell Therapy
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NERVE REPAIR AND REGENERATION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NERVE REPAIR AND REGENERATION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Neurostimulation and Neuromodulation Devices
• 5.3 Biomaterial

6 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY SURGERY

• 6.1 Overview
• 6.2 Nerve Grafting
• 6.3 Stem Cell Therapy

7 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL NERVE REPAIR AND REGENERATION MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Medtronic's Plc
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Axogen Corporation
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Baxter International Inc.
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Polygamic
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Integra LiveScience
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Cyberonics Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Stryker Corporation
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 St. Judge Medical Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Boston Scientific Corporation
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Emerson Electric Company
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research